FeaturedVerified
The Catalyst Clinic
London, United Kingdom
Specialist clinic with explicit peptide therapy pages, doctor-led positioning, and clinically framed consultation protocols.
In personFrom £220
CJC-1295 vs Ipamorelin
Reviewed by Gabriel Brocklesby · Last updated
Both are growth hormone secretagogues frequently listed together in clinic protocols. Compare provider transparency, consultation model, and follow-up structure.
CJC-1295 and ipamorelin are commonly referenced together in hormone optimisation and longevity clinic listings. Clinics vary in how they justify and monitor these protocols. Use this page to evaluate clinical governance rather than relying on peptide names alone.
CJC-1295
A growth hormone secretagogue referenced in longevity and hormone optimisation contexts.
Potential benefits
- Often listed in longevity and performance protocols.
- Typically paired with other secretagogues.
Considerations
- Evidence base varies by clinic and jurisdiction.
- Monitoring and dosing protocols differ widely.
Best for: Comparing clinics that advertise GH secretagogue pathways.
Ipamorelin
A GH secretagogue frequently listed alongside CJC-1295 in clinic programmes.
Potential benefits
- Common in hormone optimisation listings.
- Often offered in multi-peptide protocols.
Considerations
- Human evidence is limited.
- Clinic oversight models vary.
Best for: Assessing clinics that list GH secretagogues with structured monitoring.
| Category | CJC-1295 | Ipamorelin |
|---|---|---|
| Directory context | Informational clinic and treatment comparison context. | Informational clinic and treatment comparison context. |
| Common goals | Compare how clinics frame suitability, monitoring, and expected use cases. | Compare how clinics frame suitability, monitoring, and expected use cases. |
| Guidance note | Informational listing only; suitability requires clinician review. | Informational listing only; suitability requires clinician review. |
Next step
Compare clinics offering these treatments
Use city pages and peptide-specific pages to move from general research into actual provider shortlists. That usually gives a better buying picture than comparing drug names alone.
Related clinics
FeaturedVerified
Menon Health
London, United Kingdom
Menon Health is a Mayfair-based peptide therapy clinic founded by Dr Mukil Menon, a GMC-registered physician and one of the first doctors to prescribe medical peptide therapy in the UK. Before establishing Menon Health, Dr Menon served as UK medical director at Koniver Wellness, launching the clinic at Soho House London. He continues to practise within the NHS alongside his private consultations, ensuring his protocols stay grounded in current medical standards. The clinic offers doctor-led, prescription-based peptide therapy alongside regenerative cell complex treatments, bloods and diagnostics, and IV therapy. All formulations are sourced from GMP-certified, EMA-regulated pharmacies and dispensed as pre-filled pens, vials, or multi-peptide syringes — Menon Health's approach to combining multiple peptides in a single dose is designed to improve precision and patient adherence. Based at 64 North Row in Mayfair, London, Menon Health serves patients across the UK, Europe, Canada, and the United States, with consultations available in person or remotely.
In personRemoteFrom £195Virtual consultations
Iv Glow Bar
Los Angeles, CA, USA
Iv Glow Bar is an approved peptide clinic listing in Los Angeles. Services reference semaglutide, tirzepatide, bpc-157, cjc-1295, ipamorelin.
In person
Wellness Club 365
Glendale, CA, USA
Wellness Club 365 is an approved peptide clinic listing in USA. Services reference semaglutide, tirzepatide, bpc-157, cjc-1295, ipamorelin, testosterone-therapy.
In person
Conclusion
Both appear in similar clinic contexts; the quality of the provider matters most. Choose clinics that clearly explain rationale, monitoring, and contraindications.
Related peptide pages
Related goals
Related conditions
London treatment pages
US city pages
For clinics
Are you a clinic?
Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.